Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy

Br J Ophthalmol. 2001 Apr;85(4):483-95. doi: 10.1136/bjo.85.4.483.

Authors

G Soubrane¹, N M Bressler

Affiliation

¹ Clinique Ophtalmologique Universitaire de Créteil, Université Paris-Val-de-Marne, Créteil, France.

No abstract available

Publication types

Review

MeSH terms

Aged
Animals
Choroidal Neovascularization / etiology
Choroidal Neovascularization / therapy*
Clinical Trials as Topic
Haplorhini
Humans
Laser Coagulation / methods
Macular Degeneration / classification
Macular Degeneration / complications*
Macular Degeneration / therapy
Middle Aged
Photochemotherapy / methods*
Photosensitizing Agents / therapeutic use*
Porphyrins / therapeutic use*
Prognosis
Rabbits
Recurrence
Treatment Outcome
Verteporfin

Substances

Photosensitizing Agents
Porphyrins
Verteporfin